Anterra Capital raises $100M for Food Tech Fund III

The $10 trillion food industry is undergoing a seismic shift, driven by advancements in artificial intelligence. Specialist investor Anterra Capital is doubling down, announcing a $100 million first close for its third fund, positioning itself for what it calls the most attractive deployment moment in over a decade.

Fund III's Initial Close

Anterra Capital has reached $100 million for Fund III, with a target of $200 million. This milestone underscores the firm's conviction that technologies reshaping other sectors will inevitably transform food and agriculture.

"The firm has now successfully navigated two capital cycles in food and agriculture," said Maarten Goossens, Partner at Anterra Capital. "Each one rewarded the same discipline: backing companies that deliver real returns for their customers and to their investors. What's different this time is that the real-world industries we operate in, large, complex and historically resistant to change, are now ready to be rewired, and the tools to do it have arrived."

The Ripe Moment for Investment

Food and agriculture, a $10 trillion global behemoth employing nearly 40% of the world's workforce, faces unprecedented pressures. Margin volatility, food security concerns, climate change, and evolving regulations necessitate a transformation.

While previous capital cycles saw significant investment in capital-intensive ventures like vertical farms and plant-based alternatives, many failed to scale. Anterra's strategy focuses on science-backed companies with sound economics, designed to integrate with existing industry channels.

The current wave of investment in vertical AI and biological innovation is unlocking new possibilities.

AI is compressing R&D timelines and reducing the capital required for breakthroughs in biology, while also digitizing fragmented, manual workflows in sectors like agriculture.

This convergence makes it an opportune time for focused investment in the sector.

Anterra's Track Record

Anterra's consistent investment thesis has yielded multiple successful exits across its first two funds, including a Nasdaq IPO and strategic acquisitions by industry leaders.

The firm actively builds companies to fill market gaps. Enko Chem, for instance, is developing next-generation crop protection chemistry. Invetx, a veterinary biologics company built from the ground up by Anterra, was acquired for over $500 million within six years.

Investor Confidence

Anterra's investor base comprises institutional investors, food system operators, and industry innovators from North America, Europe, and APAC. This includes major financial institutions, sovereign wealth funds, and leading companies in food and animal health.

"The vote of confidence from our investor base is what gives this close its weight," stated Adam Anders, Partner at Anterra Capital. "The combination of leading global asset managers, the institutions that know our sector backwards and the operators who farm millions of acres all backing the same thesis is an unrivalled force supporting the Anterra portfolio."

Future Investments

Fund III has already made two investments. Anchr, an AI-native platform modernizing food distribution's back office, and Animerra, a veterinary biologics company founded by Anterra, leveraging advanced science with a lean team.

"We've spent twelve years and two funds proving you can build category-defining companies in food and agriculture, and generate real returns doing it," said Brett Wong, Partner at Anterra Capital. "What's changed is that the world has finally caught up to that thesis. The technology is here, the valuations make sense, and the founders building in this sector are the best we've ever seen."